Acura Pharma Balance Sheet - Quarterly (OTCMKTS:ACUR)

Add to My Stocks
$0.54 $0 (0%) ACUR stock closing price Mar 19, 2018 (Closing)

The financial analysis of a company like Acura Pharma involves checking the three financial statements of the company in detail, of which the balance sheet is one. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Acura Pharma stock analysis. Quarterly results are typically accompanied with the company releasing financial statements. Apart from analyzing Acura Pharma revenue Acura Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Acura Pharma balance sheet for 2017 Q3 shows cash on hand of $4.78M. The company has a debt to equity ratio of 2.26.

View and download Acura Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Marketable Securities-----3.51M7.68M10.83M11.92M
Raw Materials---------
Work In Progress---------
Finished Goods---------
Notes Receivable---------
Other Current Assets---------
Total Current Assets
Property Plant & Equipment---2.8M---2.75M-
Accumulated Depreciation---1.94M---1.74M-
Net Property Plant & Equipment
Investment & Advances---------
Other Non-Current Assets---------
Deferred Charges---------
Deposits & Other Assets---------
Total Assets
Notes Payable---------
Accounts Payable---------
Current Portion Long-Term Debt2.91M2.85M2.79M2.37M2.68M2.62M2.57M2.32M2.47M
Current Portion Capital Leases---------
Accrued Expenses--1.07M---1.2M--
Income Taxes Payable---------
Other Current Liabilities---------
Total Current Liabilities
Deferred Taxes/Income---------
Convertible Debt---------
Long-Term Debt-1.43M2.14M2.97M3.5M4.16M4.8M5.43M6.03M
Non-Current Capital Leases---------
Other Long-Term Liabilities---------
Total Liabilities
Minority Interest---------
Preferred Stock---------
Common Stock Net---------
Capital Surplus380.03M376M375.88M375.76M375.62M375.47M375.32M375.15M375.01M
Retained Earnings-378.64M-376.44M-374.29M-374.69M-376.23M-373.98M-370.69M-367.31M-366.39M
Treasury Stock---------
Other Liabilities--------0.06M-0.01M
Shareholders Equity1.6M-0.32M1.71M1.18M-0.48M1.63M4.75M7.9M8.72M
Total Liabilities & Shareholders Equity7.26M6.24M8.85M8.2M7.73M10.22M14.42M16.96M18.94M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Most investors just check the Acura Pharma stock price, and Acura Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Acura Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: ACUR total assets, which was at $7.26M for 2017 Q3 is a balance sheet item representing value of what Acura Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: The total liabilities of Acura Pharma for the quarter 2017 Q3 total to $5.66M. Liabilities for a company like Acura Pharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Acura Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio